{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:06:27Z","timestamp":1782821187242,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005731","name":"Juntendo University","doi-asserted-by":"publisher","award":["2019-46"],"award-info":[{"award-number":["2019-46"]}],"id":[{"id":"10.13039\/501100005731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Nontuberculous mycobacteria (NTM) are ubiquitous organisms and the incidence of NTM infections has been increasing in recent years.\n                      <jats:italic>Mycobacteroides abscessus<\/jats:italic>\n                      (\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      ) is one of the most antimicrobial-resistant NTM; however, no reliable antibiotic regimen can be officially advocated. We evaluated the efficacy of clarithromycin in combination with various antimicrobial agents against the\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      complex.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-nine clinical strains of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      were isolated from various clinical samples. Of the isolates, 10 (34.5%) were of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      subsp.\n                      <jats:italic>abscessus<\/jats:italic>\n                      , 18 (62.1%) of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      subsp.\n                      <jats:italic>massiliense<\/jats:italic>\n                      , and 1 (3.4%) of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      subsp.\n                      <jats:italic>bolletii<\/jats:italic>\n                      . MICs of three antimicrobial agents (amikacin, imipenem, and moxifloxacin) were measured with or without clarithromycin. The imipenem-clarithromycin combination significantly reduced MICs compared to clarithromycin and imipenem monotherapies, including against resistant strains. The association between susceptibility of the\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      complex and each combination of agents was significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Adjusted residuals indicated that the imipenem-clarithromycin combination had the synergistic effect (adjusted residual\u2009=\u20093.1) and suppressed the antagonistic effect (adjusted residual\u2009=\u2009\u2212\u20093.1). In subspecies of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      complex, the association with susceptibility of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      subsp.\n                      <jats:italic>massiliense<\/jats:italic>\n                      was similarly statistically significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036: adjusted residuals of synergistic and antagonistic effect respectively: 2.6 and\u2009\u2212\u20092.6). The association with susceptibility of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      subsp.\n                      <jats:italic>abscessus<\/jats:italic>\n                      also showed a similar trend but did not reach statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our data suggest that the imipenem-clarithromycin combination could be the recommended therapeutic choice for the treatment of\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      complex owing to its ability to restore antimicrobial susceptibility.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-020-02000-5","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T09:04:25Z","timestamp":1603098265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex"],"prefix":"10.1186","volume":"20","author":[{"given":"Satomi","family":"Takei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1225-6930","authenticated-orcid":false,"given":"Hiroaki","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Chonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimichi","family":"Ohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"3","key":"2000_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3201\/eid1403.061143","volume":"14","author":"EE Bodle","year":"2008","unstructured":"Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York city. Emerg Infect Dis. 2008;14(3):390\u20136.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"2000_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","volume":"182","author":"DR Prevots","year":"2010","unstructured":"Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Resp Crit Care. 2010;182(7):970\u20136.","journal-title":"Am J Resp Crit Care"},{"issue":"6","key":"2000_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Kurashima A, Morimoto K, et al. Epidemiology of pulmonary Nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22(6):1116\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"2000_CR4","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01257-09","volume":"47","author":"AL Roux","year":"2009","unstructured":"Roux AL, Catherinot E, Ripoll F, et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol. 2009;47(12):4124\u20138.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2000_CR5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","volume":"167","author":"KN Olivier","year":"2003","unstructured":"Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167(6):828\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2000_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1128\/AAC.28.6.807","volume":"28","author":"JM Swenson","year":"1985","unstructured":"Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985;28(6):807\u201311.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2000_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1128\/AAC.36.1.180","volume":"36","author":"BA Brown","year":"1992","unstructured":"Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992;36(1):180\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2000_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2000_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3201\/eid2203.150828","volume":"22","author":"SA Novosad","year":"2016","unstructured":"Novosad SA, Beekmann SE, Polgreen PM, Mackey K, Winthrop KL. Team MaS. Treatment of Mycobacterium abscessus infection. Emerg Infect Dis. 2016;22(3):511\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"2000_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1128\/AAC.00861-10","volume":"55","author":"S Bastian","year":"2011","unstructured":"Bastian S, Veziris N, Roux AL, et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing. Antimicrob Agents Ch. 2011;55(2):775\u201381.","journal-title":"Antimicrob Agents Ch"},{"issue":"6","key":"2000_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","volume":"54","author":"HY Kim","year":"2010","unstructured":"Kim HY, Kim BJ, Kook Y, et al. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol. 2010;54(6):347\u201353.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"2000_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1513\/AnnalsATS.201304-085OC","volume":"11","author":"J Adjemian","year":"2014","unstructured":"Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9\u201316.","journal-title":"Ann Am Thorac Soc"},{"key":"2000_CR13","volume-title":"Antibiotics in laboratory medicine","author":"V Lorian","year":"1996","unstructured":"Lorian V. Antibiotics in laboratory medicine. 4th ed. Baltimore: Williams & Wilkins; 1996.","edition":"4"},{"issue":"10","key":"2000_CR14","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1128\/AAC.00990-16","volume":"60","author":"BE Ferro","year":"2016","unstructured":"Ferro BE, Srivastava S, Deshpande D, et al. Failure of the Amikacin, Cefoxitin, and clarithromycin combination regimen for treating pulmonary Mycobacterium abscessus infection. Antimicrob Agents Chemother. 2016;60(10):6374\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2000_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/infdis\/jit614","volume":"209","author":"I Lerat","year":"2014","unstructured":"Lerat I, Cambau E, Roth Dit Bettoni R, et al. In vivo evaluation of antibiotic activity against Mycobacterium abscessus. J Infect Dis. 2014;209(6):905\u201312.","journal-title":"J Infect Dis"},{"key":"2000_CR16","doi-asserted-by":"publisher","unstructured":"Pasipanodya JG, Ogbonna D, Ferro BE, et al. Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence. Antimicrob Agents Chemother. 2017;61(11):e01206-17. https:\/\/doi.org\/10.1128\/AAC.01206-17.","DOI":"10.1128\/AAC.01206-17"},{"key":"2000_CR17","doi-asserted-by":"publisher","unstructured":"Le Run E, Arthur M, Mainardi JL. In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. Antimicrob Agents Chemother. 2018;62(8):e00623-18. https:\/\/doi.org\/10.1128\/AAC.00623-18.","DOI":"10.1128\/AAC.00623-18"},{"issue":"6","key":"2000_CR18","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/jac\/dkw022","volume":"71","author":"AL Lefebvre","year":"2016","unstructured":"Lefebvre AL, Dubee V, Cortes M, Dorchene D, Arthur M, Mainardi JL. Bactericidal and intracellular activity of beta-lactams against Mycobacterium abscessus. J Antimicrob Chemother. 2016;71(6):1556\u201363.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2000_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijantimicag.2007.05.003","volume":"30","author":"T Miyasaka","year":"2007","unstructured":"Miyasaka T, Kunishima H, Komatsu M, et al. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus. Int J Antimicrob Agents. 2007;30(3):255\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"2000_CR20","doi-asserted-by":"publisher","unstructured":"Kim BJ, Yi SY, Shim TS, et al. Discovery of a Novel hsp65 Genotype within Mycobacterium massiliense Associated with the Rough Colony Morphology. Plos One. 2012;7(6):e38420. https:\/\/doi.org\/10.1371\/journal.pone.0038420.","DOI":"10.1371\/journal.pone.0038420"},{"issue":"3","key":"2000_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijantimicag.2013.04.029","volume":"42","author":"S Yoshida","year":"2013","unstructured":"Yoshida S, Tsuyuguchi K, Suzuki K, et al. Further isolation of Mycobacterium abscessus subsp abscessus and subsp bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents. Int J Antimicrob Ag. 2013;42(3):226\u201331.","journal-title":"Int J Antimicrob Ag"},{"issue":"11","key":"2000_CR22","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/JCM.01536-13","volume":"51","author":"K Sparbier","year":"2013","unstructured":"Sparbier K, Lange C, Jung J, et al. MALDI Biotyper-based rapid resistance detection by stable-isotope labeling. J Clin Microbiol. 2013;51(11):3741\u20138.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2000_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/JCM.01327-13","volume":"52","author":"K Nakanaga","year":"2014","unstructured":"Nakanaga K, Sekizuka T, Fukano H, et al. Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in clinical isolates by multiplex PCR. J Clin Microbiol. 2014;52(1):251\u20139.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2000_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1128\/JCM.02950-14","volume":"53","author":"BA Brown-Elliott","year":"2015","unstructured":"Brown-Elliott BA, Vasireddy S, Vasireddy R, et al. Utility of sequencing the erm (41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol. 2015;53(4):1211\u20135.","journal-title":"J Clin Microbiol"},{"key":"2000_CR25","doi-asserted-by":"crossref","unstructured":"Woods GL, Brown-Elliott BA, Conville PS, et al. In: nd, ed. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Wayne: Clinical and Laboratory Standards Institute; 2011.","DOI":"10.1128\/9781555816728.ch73"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-020-02000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-020-02000-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-020-02000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T16:43:17Z","timestamp":1669221797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-020-02000-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1186\/s12866-020-02000-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-33042\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33042\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33042\/v1","asserted-by":"object"}]},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Independent Ethics Committee at Juntendo University Hospital (approval no. 18\u2013010 and 19\u2013038) and adhered to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}